+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

From
From
Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025 - Product Thumbnail Image

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025

  • Report
  • September 2025
  • 250 Days
  • Global
From
From
Diabetes Injection Pens - Global Strategic Business Report - Product Thumbnail Image

Diabetes Injection Pens - Global Strategic Business Report

  • Report
  • January 2026
  • 193 Pages
  • Global
From
From
From
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025 - Product Thumbnail Image

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025

  • Report
  • September 2025
  • 300 Pages
  • Global
From
From
From
From
Prediabetes Market - Global Strategic Business Report - Product Thumbnail Image

Prediabetes Market - Global Strategic Business Report

  • Report
  • January 2026
  • 287 Pages
  • Global
From
Type 1 Diabetes Market - Global Strategic Business Report - Product Thumbnail Image

Type 1 Diabetes Market - Global Strategic Business Report

  • Report
  • January 2026
  • 476 Pages
  • Global
From
From
From
Insulin Pump Market - Global Outlook and Forecast 2023-2028 - Product Thumbnail Image

Insulin Pump Market - Global Outlook and Forecast 2023-2028

  • Report
  • March 2023
  • 279 Pages
  • Global
From
From
From
Loading Indicator